Navigation

ExploreAnalysisInvestor RelationsAI AssistantCompareScreener
LoginSign Up FreeSign Up

© 2026 MarketCI. All rights reserved.

HelpPricingPrivacyTerms
WS

WST

Market Closed

West Pharmaceutical Services, Inc.

NYSEHealthcareMedical - Instruments & Supplies
US
10.80K employees
CEO: Michel Lagarde
Founded: 1980
$413.09
+$0.00(+NaN%)
Market Cap
28.78B
Beta
1.14
52W Range
N/A
Dividend Yield
0.21%
OverviewForecastsFundamentalMarket SentimentValuationOwnership
OverviewForecastsFundamentalMarket SentimentValuationOwnership
Comprehensive Valuation
In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: West Pharmaceutical Services trades 53% above its high-confidence fair value average of $195, indicating potential overvaluation despite strong financial health. Monte Carlo analysis shows high downside risk with all scenarios below the current price and volatility at 45.6%. Valuation methods reveal divergence: conservative DCF estimates are much lower than analyst targets, suggesting differing growth assumptions.
Enhanced Football Field Analysis
Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore WST

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

WST in the Healthcare

Large Cap
Healthcare

Browse sector stocks →

Medical - Instruments & Supplies

Browse industry stocks →